Palbociclib: a new partner for cetuximab?

Lancet Oncol. 2019 Sep;20(9):1195-1196. doi: 10.1016/S1470-2045(19)30484-X. Epub 2019 Jul 24.

Authors

Garth W Strohbehn¹, Everett E Vokes²

Affiliations

¹ Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, The University of Chicago, Chicago, IL 60637, USA.
² Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, The University of Chicago, Chicago, IL 60637, USA. Electronic address: evokes@medicine.bsd.uchicago.edu.

PMID: 31351868
DOI: 10.1016/S1470-2045(19)30484-X

No abstract available

Publication types

Comment

MeSH terms

Cetuximab
Head and Neck Neoplasms*
Humans
Papillomaviridae*
Papillomavirus Infections*
Piperazines
Platinum
Pyridines

Substances

Piperazines
Pyridines
Platinum
palbociclib
Cetuximab